|
|
.
See Category: Diseases of the eye and adnexa
See Header: Central retinal vein occlusion, left eye
ICD-10 (CM) Code and Descriptor
|
H34.8121 |
Central retinal vein occlusion, left eye, with retinal neovascularization
|
H348121 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 50.45%
|
24.55%
|
11.97%
|
4.09%
|
2.73%
|
2.58%
|
0.91%
|
1.06%
|
0.15%
|
0.15%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for H34.8121*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
92134
|
CPTRZ OPH DX IMG PST SGM RTA |
170
|
170
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
149
|
150
|
|
67028
|
INJECTION EYE DRUG |
122
|
122
|
|
C9257
|
BEVACIZUMAB INJECTION |
80
|
381
|
|
67228
|
TREATMENT X10SV RETINOPATHY |
50
|
50
|
|
92014
|
COMPRE OPH EXAM EST PT 1/> |
47
|
47
|
|
J0178
|
AFLIBERCEPT INJECTION |
20
|
40
|
|
92250
|
FUNDUS PHOTOGRAPHY W/I&R |
18
|
18
|
|
92235
|
FLUORESCEIN ANGRPH MLTIFRAME |
16
|
16
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
15
|
15
|
|
76512
|
OPH US DX B-SCAN |
14
|
14
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
11
|
11
|
|
J3490
|
DRUGS UNCLASSIFIED INJECTION |
9
|
30
|
|
92012
|
INTRM OPH EXAM EST PATIENT |
9
|
9
|
|
J2704
|
INJ, PROPOFOL, 10 MG |
8
|
198
|
|
J3010
|
FENTANYL CITRATE INJECTION |
8
|
12
|
|
82962
|
GLUCOSE BLOOD TEST |
8
|
10
|
|
92201
|
OPSCPY EXTND RTA DRAW UNI/BI |
7
|
7
|
|
J7999
|
COMPOUNDED DRUG, NOC |
7
|
8
|
|
92202
|
OPSCPY EXTND ON/MAC DRAW |
7
|
7
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
H34.8121 related to the following DRG Codes:
123
|
